BeOne Medicines
ONC
#636
Rank
$39.83 B
Marketcap
$350.13
Share price
-3.82%
Change (1 day)
2.49%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Financial Statements

Thumbnail BeOne Medicines Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement